Neuronetics Total Stockholder Equity vs Inventory Analysis
STIM Stock | USD 1.92 0.02 1.05% |
Neuronetics financial indicator trend analysis is infinitely more than just investigating Neuronetics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neuronetics is a good investment. Please check the relationship between Neuronetics Total Stockholder Equity and its Inventory accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
Total Stockholder Equity vs Inventory
Total Stockholder Equity vs Inventory Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neuronetics Total Stockholder Equity account and Inventory. At this time, the significance of the direction appears to have strong relationship.
The correlation between Neuronetics' Total Stockholder Equity and Inventory is 0.73. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Inventory in the same time period over historical financial statements of Neuronetics, assuming nothing else is changed. The correlation between historical values of Neuronetics' Total Stockholder Equity and Inventory is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Neuronetics are associated (or correlated) with its Inventory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory has no effect on the direction of Total Stockholder Equity i.e., Neuronetics' Total Stockholder Equity and Inventory go up and down completely randomly.
Correlation Coefficient | 0.73 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Inventory
Most indicators from Neuronetics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neuronetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.As of the 1st of June 2024, Selling General Administrative is likely to drop to about 19.4 M. In addition to that, Issuance Of Capital Stock is likely to drop to 0.00
2023 | 2024 (projected) | Depreciation And Amortization | 2.0M | 1.8M | Interest Income | 4.2M | 3.3M |
Neuronetics fundamental ratios Correlations
Click cells to compare fundamentals
Neuronetics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neuronetics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 100.2M | 78.7M | 141.2M | 116.9M | 115.8M | 100.9M | |
Short Long Term Debt Total | 34.3M | 38.3M | 39.5M | 39.7M | 62.5M | 40.5M | |
Other Current Liab | 9.0M | 7.3M | 8.2M | 14.8M | 12.6M | 10.1M | |
Total Current Liabilities | 27.7M | 13.7M | 15.7M | 33.2M | 19.8M | 20.5M | |
Total Stockholder Equity | 47.9M | 25.5M | 85.2M | 57.1M | 34.2M | 35.9M | |
Other Liab | 2.1M | 1.7M | 1.5M | 829K | 746.1K | 1.2M | |
Net Tangible Assets | 46.7M | 25.5M | 85.2M | 57.1M | 65.6M | 68.9M | |
Property Plant And Equipment Net | 4.9M | 4.1M | 5.1M | 5.3M | 4.8M | 3.9M | |
Current Deferred Revenue | 2.2M | 2.0M | 2.5M | 2.0M | 1.6M | 2.2M | |
Net Debt | (41.4M) | (10.6M) | (54.6M) | (30.6M) | 2.8M | 2.9M | |
Retained Earnings | (250.1M) | (277.5M) | (308.7M) | (345.9M) | (376.1M) | (394.9M) | |
Accounts Payable | 4.6M | 3.7M | 4.3M | 2.4M | 4.8M | 3.8M | |
Cash | 75.7M | 49.0M | 94.1M | 70.3M | 59.7M | 68.7M | |
Non Current Assets Total | 11.7M | 13.6M | 25.9M | 18.1M | 22.0M | 13.4M | |
Non Currrent Assets Other | 5.1M | 7.2M | 19.1M | 11.6M | 12.8M | 7.9M | |
Other Assets | 5.6M | 12.9M | 167.1M | 9.2M | 1.0 | 0.95 | |
Long Term Debt | 19.9M | 34.6M | 35.3M | 22.8M | 59.3M | 34.0M | |
Cash And Short Term Investments | 76.6M | 50.8M | 96.3M | 71.9M | 60.6M | 69.7M | |
Net Receivables | 6.6M | 7.2M | 7.8M | 13.8M | 17.8M | 9.2M | |
Common Stock Total Equity | 177K | 186K | 191K | 273K | 314.0K | 329.6K | |
Common Stock Shares Outstanding | 18.4M | 18.8M | 25.5M | 26.9M | 28.7M | 17.5M | |
Long Term Debt Total | 30.4M | 19.9M | 34.6M | 22.8M | 26.3M | 28.2M | |
Liabilities And Stockholders Equity | 100.2M | 78.7M | 141.2M | 116.9M | 115.8M | 100.9M | |
Non Current Liabilities Total | 24.6M | 39.5M | 40.3M | 26.6M | 61.8M | 63.4M | |
Capital Surpluse | 291.9M | 297.8M | 302.8M | 402.7M | 463.1M | 238.9M | |
Inventory | 2.8M | 3.7M | 6.6M | 8.9M | 8.1M | 5.0M | |
Other Current Assets | 2.5M | 3.3M | 4.6M | 2.2M | 7.3M | 7.6M | |
Other Stockholder Equity | 297.8M | 302.8M | 393.6M | 402.7M | 410.0M | 274.4M | |
Total Liab | 52.3M | 53.2M | 56.0M | 59.8M | 81.6M | 78.2M | |
Property Plant And Equipment Gross | 4.9M | 4.1M | 5.1M | 5.3M | 7.6M | 4.3M | |
Total Current Assets | 88.5M | 65.0M | 115.3M | 98.8M | 93.8M | 87.4M | |
Common Stock | 186K | 191K | 264K | 273K | 291K | 190.6K | |
Property Plant Equipment | 4.9M | 730K | 5.1M | 2.0M | 2.3M | 2.7M | |
Net Invested Capital | 79M | 60.1M | 120.5M | 93.0M | 93.5M | 60.4M | |
Net Working Capital | 60.8M | 51.3M | 99.6M | 65.6M | 74.0M | 75.0M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Neuronetics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Neuronetics Stock analysis
When running Neuronetics' price analysis, check to measure Neuronetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuronetics is operating at the current time. Most of Neuronetics' value examination focuses on studying past and present price action to predict the probability of Neuronetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuronetics' price. Additionally, you may evaluate how the addition of Neuronetics to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Neuronetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 2.523 | Quarterly Revenue Growth 0.121 | Return On Assets (0.15) | Return On Equity (0.72) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.